The ONLY event dedicated to macrophage therapeutics & applications beyond oncology
The 6th Macrophage-Directed Therapies Summit is uniting biopharma and academia leaders across R&D, Discovery, Biology, Translational, and Clinical Development to confront the most pressing challenges in the space, with crucial discussions on the current investment landscape, giving you the information needed to secure strategic partnerships and navigate the evolving funding environment.
Despite toxicity concerns for CD47 targets in 2023, the macrophage community understands the critical importance of advancing revolutionary treatments for oncology, autoimmunity, inflammation, neurodegenerative disorders, and beyond, making this work more vital than ever.
Join a community that prevails
Meet top leaders
This is your chance to gain first-hand knowledge and network with top institutions like Carisma Therapeutics, Resolution Therapeutics, Harvard Medical School, and Johns Hopkins School of Medicine, as they unravel the latest discoveries in macrophage biology and drive us closer to proof-of-concept data.
Key Highlights
Assessing the evolving macrophage-therapeutics landscape to uncover innovative targets and the latest data
Exploring indications for extending beyond oncology to autoimmunity, inflammation, and neurodegenerative diseases
Discussing novel approaches that promise to pioneer the next generation of CAR-M therapies
Download the Full Agenda for More Information on:
-
-
-
- 28+ Macrophage Expert Speakers
- 3 Interactive Deep-Dive Workshops
- 8+ Hours of Industry Networking
- & Much More!
-
-
World-Class Speaker Faculty Includes
Our 2024 Partners
